DESPITE nervy times in China, mainboard-listed Vicplas International will stick to its plan to open its third and latest medical technology (medtech) manufacturing outlet in Changzhou next month — ramping up its medical devices production capacity in the country by 60 per cent.

The building and construction sector faces an intact recovery despite macro challenges, say CGS-CIMB Research analysts Ong Khang Chuen and Kenneth Tan.In a May 4 note, Ong and Tan are maintaining “overweight” on the sector. CGS-CIMB hosted BRC Asia, Pan-United Corporation and Vicplas Internation...

Vicplas International has reported earnings of $5.02 million for the 1HFY2022 ended January, 0.6% higher than earnings of $4.99 million in the corresponding period a year ago. The earnings growth was attributable to a growth in the half-year revenue and offset by the higher costs in energy and raw m...

CGS-CIMB on Wednesday (Jan 26) initiated coverage on Vicplas International with an "add" call and a target price of S$0.275.

CGS-CIMB analyst William Tng has initiated coverage on Vicplas with an “add” call and a target price of 27.5 cents. In a Jan 25 note, Tng points out that the company is tapping into the “medical contract manufacturing space” for growth. He projects a 10.8% earnings per share (EPS) compound a...

Vicplas International has appointed Walter Tarca as its deputy group CEO as part of its succession plan. Tarca’s appointment will take effect from Feb 1. He will continue to work alongside group CEO Cheng Liang and will assume the role of group CEO from Aug 1. Tarca has been the president of the...

The pandemic has made entire industries and companies to be either winners or losers. Medical and essential prod­ucts suppliers sit on record earnings while construction firms, ho­tels and airlines nurse their wounds. Interestingly, contract manufactur­er Vicplas International finds itself stradd...

Vicplas International has posted earnings of $10.4 million for FY2021 ended July, up 112.5% from $4.9 million the previous year. This translates to earnings per share of 2 cents on a fully diluted basis, up from 0.98 cents the previous year. Revenue for the period increased by 28.2% to $113.9 millio...

Mainboard-listed Vicplas International achieved earnings of $5 million for the 1HFY2021 ended January 31, representing a 120% growth y-o-y from $2.3 million previously. The increase in earnings follows higher revenue and other income for the period. Revenue grew 19.8% y-o-y from $47.2 million to $56...

SHARES of Vicplas International, which makes medical devices and pipes, sagged on Monday despite an improvement in the group's bottom line for its fiscal year ended July 31.